drugset / Trial / NCT01460212

Magnetic Resonance Imaging Study of Cognitive-Behavior Therapy for Major Depressive Disorder

NCT01460212

Phase 4 Unknown 80 enrolled Nanjing Medical University
RandomizedParallel-groupOpen-labelTreatment

Summary

Study hypothesis: psychotherapy and SSRI treatment effect in different brain way: psychotherapy in "up to down" way and SSRI in "down to up" way. The investigators will explore this hypothesis in major depressive disorder outpatients with Magnetic Resonance Imaging analysis in this study. Patients in different groups will be treated by psychotherapy or SSRI treatment. They will all be checked with Magnetic Resonance Imaging pro and after 12 weeks of treatment.

Timeline

Start
2011-12
Primary completion
2014-12
Completion
2015-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Citalopram Small molecule
Comparator Escitalopram Small molecule
Comparator Fluoxetine Small molecule
Comparator Fluvoxamine Unknown
Comparator Paroxetine Small molecule
Comparator Sertraline Small molecule